Is ritexitinib already on the market in the country?

Ritlecitinib is a targeted drug used to treat atopic dermatitis (ie, eczema) and is currently on the market in China. It is a new type of JAK inhibitor that can alleviate the inflammatory response caused by immune system abnormalities by inhibiting the activity of JAK enzyme. The launch of ritexitinib provides a new treatment option for domestic patients with atopic dermatitis, especially those who are ineffective with traditional treatments. It can help improve skin symptoms and reduce the recurrence of the disease.

Although ritexitinib is already on the market in China, it is not yet included in the medical insurance system, which means that patients need to pay for it out of pocket. The market price of ritexitinib is approximately more than 3,000 yuan per box, and the specific price may vary depending on regions and pharmacies. Therefore, patients should consult the local hospital pharmacy in advance when purchasing to learn about the latest price information and possible preferential policies. At the same time, since there is no medical insurance reimbursement, the financial burden may be greater for patients, especially those who require long-term treatment.

For patients looking for a more economical option, relatively inexpensive generic versions of ritexitinib are available in overseas markets. Compared with the original drugs, the price of generic drugs produced in Laos has dropped significantly. The price of 120 tablets is about more than 1,000 yuan, which is much lower than the price of the original drugs. Moreover, the ingredients of these generic drugs are basically the same as those of the original drugs, and their efficacy and safety have been verified. Therefore, patients can choose imported generic drugs according to their needs to reduce their financial burden.

Generally speaking, ritixitinib, as a new targeted therapy drug, has been launched in China and is available for purchase. However, since it is not covered by medical insurance, the price is relatively high. Therefore, patients need to choose the most appropriate purchase method based on their personal circumstances. Regardless of whether they choose original drugs or generic drugs, patients should fully communicate with their doctors before use to ensure the safety and therapeutic effect of the drugs, and conduct long-term follow-up treatment according to the doctor's recommendations.

Reference materials:https://www.litfulo.com/